SCHEMBL14935964

SCHEMBL14935964

Cc1cccc2c1oc1c(-c3ccccn3)cccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
MITF O75030 1/20 0.47
GAA P10253 1/20 0.47
PKM P14618 1/20 0.47
RAB9A P51151 1/20 0.47
KCNA3 P22001 1/20 0.43
KDM4E B2RXH2 4/20 0.42
TP53 P04637 2/20 0.42
MAPK1 P28482 2/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
HSD17B10 Q99714 1/20 0.42
BRD4 O60885 1/20 0.42
JAK2 O60674 1/20 0.42
JAK1 P23458 1/20 0.42
TYK2 P29597 1/20 0.42
JAK3 P52333 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24523701 0.90 KDM4E (0.50) NPC1SMN1; SMN2L3MBTL1PKMRAB9A
SCHEMBL22402329 0.83 KDM4E (0.41) NPC1SMN1; SMN2L3MBTL1MITFGAA
SCHEMBL29496500 0.82 PRKDC (0.46) NPC1SMN1; SMN2L3MBTL1PKMRAB9A
SCHEMBL14936359 0.82 PRKDC (0.46) NPC1SMN1; SMN2L3MBTL1PKMRAB9A
SCHEMBL21912923 0.82 TGFBR1 (0.45) NPC1SMN1; SMN2L3MBTL1MITFGAA
SCHEMBL22722345 0.82 PRKDC (0.54) NPC1SMN1; SMN2RAB9AALDH1A1HPGD
SCHEMBL24523458 0.81 CCR1 (0.44) NPC1SMN1; SMN2RAB9ACCR1CCR5
SCHEMBL12339130 0.81 CYP1A2 (0.50) NPC1SMN1; SMN2L3MBTL1MITFGAA
SCHEMBL24425926 0.81 KCNA3 (0.42) NPC1SMN1; SMN2L3MBTL1MITFGAA
SCHEMBL17573746 0.81 JAK2 (0.38) NPC1SMN1; SMN2L3MBTL1RAB9AKCNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4329431-A2 NOVEL HETEROLEPTIC IRIDIUM COMPLEXES Universal Display Corporation (US) 2024-02-28 EP disclosed
EP-4329431-A2 NOVEL HETEROLEPTIC IRIDIUM COMPLEXES Universal Display Corporation (US) 2024-02-28 EP disclosed
EP-3971197-B1 NOVEL HETEROLEPTIC IRIDIUM COMPLEXES UNIVERSAL DISPLAY CORP (US) 2024-01-03 EP disclosed
EP-3971197-A1 NOVEL HETEROLEPTIC IRIDIUM COMPLEXES Universal Display Corporation (US) 2022-03-23 EP disclosed
EP-3578564-B1 NOVEL HETEROLEPTIC IRIDIUM COMPLEXES UNIVERSAL DISPLAY CORP (US) 2021-11-24 EP disclosed
EP-3578564-B1 NOVEL HETEROLEPTIC IRIDIUM COMPLEXES UNIVERSAL DISPLAY CORP (US) 2021-11-24 EP disclosed
EP-3578564-A1 NOVEL HETEROLEPTIC IRIDIUM COMPLEXES Universal Display Corporation (US) 2019-12-11 EP disclosed
EP-3578564-A1 NOVEL HETEROLEPTIC IRIDIUM COMPLEXES Universal Display Corporation (US) 2019-12-11 EP disclosed
EP-3281944-B1 NOVEL HETEROLEPTIC IRIDIUM COMPLEXES UNIVERSAL DISPLAY CORP (US) 2019-08-07 EP disclosed
EP-3281944-B1 NOVEL HETEROLEPTIC IRIDIUM COMPLEXES UNIVERSAL DISPLAY CORP (US) 2019-08-07 EP disclosed
EP-2857409-A1 Novel Heteroleptic Iridium Complexes Universal Display Corporation (US) 2015-04-08 EP disclosed
WO-2015046916-A1 A COMBINATION OF A HOST COMPOUND AND A DOPANT COMPOUND ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2015-04-02 WO disclosed
US-20150060791-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2015-03-05 US disclosed
US-20150060791-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2015-03-05 US disclosed
EP-2594573-B1 Novel heteroleptic iridium complexes UNIVERSAL DISPLAY CORP (US) 2014-12-24 EP disclosed
EP-2594573-B1 Novel heteroleptic iridium complexes UNIVERSAL DISPLAY CORP (US) 2014-12-24 EP disclosed
EP-2594573-A1 Novel heteroleptic iridium complexes Universal Display Corporation (US) 2013-05-22 EP disclosed
US-20130119354-A1 HETEROLEPTIC IRIDIUM COMPLEX UNIVERSAL DISPLAY CORPORATION (US) 2013-05-16 US disclosed
US-20130119354-A1 HETEROLEPTIC IRIDIUM COMPLEX UNIVERSAL DISPLAY CORPORATION (US) 2013-05-16 US disclosed
US-20130119354-A1 HETEROLEPTIC IRIDIUM COMPLEX UNIVERSAL DISPLAY CORPORATION (US) 2013-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130119354-A1 HETEROLEPTIC IRIDIUM COMPLEX OCIAD1, OCIAD2, JUND NPC1 810/4885SMN1; SMN2 3575/4885L3MBTL1 3255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.